A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly ...

Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, including pharmaceuticals, industrial enzymes, and diagnostic antibodies.

The larvae of the black soldier fly (Hermetia illucens) are considered a promising source of sustainable protein, as they contain high-quality protein comparable to soy protein. They can produce this ...

Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

Scientists from the National University of Singapore (NUS) have developed a biochemical technique that captures fleeting ...

Proteins are among the most important molecular building blocks of life. They are chains of amino acids assembled in our cells by ribosomes, the molecular "protein factories" of our bodies. The ...

It’s well-established that cell-free protein synthesis (CFPS) is a highly efficient way to produce complex therapeutic proteins and that vesicle delivery systems are very effective transport systems.

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce ...

Bioprocessors can make therapeutic proteins with a variety of techniques, from batch and fed-batch processing to perfusion and hybrid systems. No matter how a bioprocessor makes a therapeutic protein, ...

Pichia pastoris has emerged as a central microbial host for recombinant protein production, offering a unique balance of rapid growth, capacity for post‐translational modifications, and ease of ...